TRIEU VUONG (CEO and Chairman of the Board) purchased 0.3% of their position (50.50K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/23/2020ACC: 0001493152-20-022256
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+50.50K
Net shares
Net buyer
$9.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50.50K
Price / share
$0.19
Trade value
$9.60K
% of position
0.3%
11/19/2020
15.76M→15.81M
Total
Net shares
+50.50K
Net value
$9.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2020 | P · Purchase | +50.50K | $0.19 | $9.60K | 0.3% | 15.76M | 15.81M |
| Total | +50.50K | $9.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2.93M
Common Stock
IndirectShares owned1.20M
Total
4.13M indirect4.13M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.93M | Indirect |
| Common Stock | 1.20M | Indirect |
| Total | 4.13M | 4.13M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported